Stock listing

900964 Stock Price, News, Filings & Events — Neurocrine Biosciences, Inc.

Selected listing: 900964 · LSX · EUR · DE

The selected listing for Neurocrine Biosciences, Inc. is 900964:LSX. Neurocrine focuses on developing and commercializing innovative therapies for neurological and endocrine disorders, aiming to improve patient outcomes. With a significant market capitalization of around €17.18 billion, the company is actively involved in advancing treatments that address unmet medical needs. Recent news and filings highlight its ongoing commitment to research and development in the healthcare sector.

900964:LSXEURDEUpdated July 24, 2026
Neurocrine Biosciences, Inc. logo
Ticker
900964:LSX
Asset type
Stock
Market cap
$17.67B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Neurocrine Biosciences, Inc. 900964:LSX stock context

The selected listing for Neurocrine Biosciences, Inc. is 900964:LSX. Neurocrine focuses on developing and commercializing innovative therapies for neurological and endocrine disorders, aiming to improve patient outcomes. With a significant market capitalization of around €17.18 billion, the company is actively involved in advancing treatments that address unmet medical needs. Recent news and filings highlight its ongoing commitment to research and development in the healthcare sector.

Research Neurocrine Biosciences, Inc.

Alternate listings